These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2738911

  • 1. Regulation of plasma complement C4 and factor b levels in murine systemic lupus erythematosus.
    Garlepp MJ, Hart DA, Fritzler MJ.
    J Clin Lab Immunol; 1989 Mar; 28(3):137-41. PubMed ID: 2738911
    [Abstract] [Full Text] [Related]

  • 2. Plasma proteinase regulation during disease progression in murine models of SLE.
    Hart DA, Garlepp M, Fritzler M.
    J Clin Lab Immunol; 1989 Sep; 30(1):27-34. PubMed ID: 2701743
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of inflammatory stimuli on murine plasma C4 and factor B concentrations.
    Garlepp MJ, Fritzler MJ, Hart DA.
    Clin Invest Med; 1988 Oct; 11(5):341-6. PubMed ID: 3052973
    [Abstract] [Full Text] [Related]

  • 4. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
    Lu Q, Shen N, Li XM, Chen SL.
    Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
    [Abstract] [Full Text] [Related]

  • 5. Responses of B cells from autoimmune mice to IL-5.
    Umland SP, Go NF, Cupp JE, Howard M.
    J Immunol; 1989 Mar 01; 142(5):1528-35. PubMed ID: 2783944
    [Abstract] [Full Text] [Related]

  • 6. Resistance to tolerance induction is not prerequisite to development of murine SLE.
    Izui S, Masuda K.
    J Immunol; 1984 Dec 01; 133(6):3010-4. PubMed ID: 6491280
    [Abstract] [Full Text] [Related]

  • 7. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
    Meryhew NL, Shaver C, Messner RP, Runquist OA.
    J Lab Clin Med; 1991 Mar 01; 117(3):181-93. PubMed ID: 2002275
    [Abstract] [Full Text] [Related]

  • 8. Oncogene expression in autoimmune mice.
    Mountz JD, Mushinski JF, Mark GE, Steinberg AD.
    J Mol Cell Immunol; 1985 Mar 01; 2(3):121-31. PubMed ID: 3916923
    [Abstract] [Full Text] [Related]

  • 9. Expansion and high proliferative potential of the macrophage system throughout life time of lupus-prone NZB/W and MRL lpr/lpr mice. Lack of down-regulation of extramedullar macrophage proliferation in the postnatal period.
    Müller M, Emmendörffer A, Lohmann-Matthes ML.
    Eur J Immunol; 1991 Sep 01; 21(9):2211-7. PubMed ID: 1889463
    [Abstract] [Full Text] [Related]

  • 10. Influence of biological response modifiers of bacterial origin on disease progression in the MRL-lpr model of systemic lupus erythematosus.
    Hart DA, Krause G, Martin L, Garlepp M, Fritzler MJ.
    Clin Invest Med; 1991 Feb 01; 14(1):55-62. PubMed ID: 2040105
    [Abstract] [Full Text] [Related]

  • 11. The effect of thymectomy on lupus-prone mice.
    Hang L, Theofilopoulos AN, Balderas RS, Francis SJ, Dixon FJ.
    J Immunol; 1984 Apr 01; 132(4):1809-13. PubMed ID: 6142069
    [Abstract] [Full Text] [Related]

  • 12. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
    Treadwell EL, Cohen P, Williams D, O'Brien K, Volkman A, Eisenberg R.
    J Immunol; 1993 Jan 15; 150(2):695-9. PubMed ID: 8419494
    [Abstract] [Full Text] [Related]

  • 13. Immunopathology of murine lupus-overview, SL/Ni and MRL/Mp-lpr/lpr-.
    Kyogoku M, Nose M, Sawai T, Miyazawa M, Tachiwaki O, Kawashima M.
    Prog Clin Biol Res; 1987 Jan 15; 229():95-130. PubMed ID: 3601997
    [Abstract] [Full Text] [Related]

  • 14. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K, Kozono Y, Waldschmidt TJ, Berthiaume D, Quigg RJ, Baron A, Holers VM.
    J Immunol; 1997 Aug 01; 159(3):1557-69. PubMed ID: 9233655
    [Abstract] [Full Text] [Related]

  • 15. The tissue specific elevation in synthesis of the 90 kDa heat shock protein precedes the onset of disease in lupus prone MRL/lpr mice.
    Faulds GB, Isenberg DA, Latchman DS.
    J Rheumatol; 1994 Feb 01; 21(2):234-8. PubMed ID: 8182630
    [Abstract] [Full Text] [Related]

  • 16. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H, Yoshida M, Izui S, Lambert PH.
    J Clin Invest; 1985 Aug 01; 76(2):685-94. PubMed ID: 3875630
    [Abstract] [Full Text] [Related]

  • 17. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 18. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ.
    J Immunol; 1998 Dec 15; 161(12):6999-7006. PubMed ID: 9862736
    [Abstract] [Full Text] [Related]

  • 19. A search for common immunological abnormalities at the onset of murine lupus in two genetically different strains.
    Morrison LJ, Menzies CB, Behan WM, Behan PO.
    J Clin Lab Immunol; 1989 Dec 15; 30(4):157-62. PubMed ID: 2577149
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun 15; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.